Logo

American Heart Association

  21
  0


Final ID: MP2726

Impact of Disease-Causing Cardiomyopathy Variants on the Risk of Atrial Fibrillation and Ventricular Cardiomyopathies in the UK Biobank

Abstract Body (Do not enter title and authors here): Background: Atrial fibrillation (AF) is heritable and its complex underlying genetic substrate is gradually being unravelled. We examined the impact of putative disease-causing ventricular cardiomyopathy variants (PDCv) on AF and ventricular cardiomyopathy risk in the UK Biobank (UKB).
Methods: Cox regression was used to evaluate for associations between PDCv within ClinGen “Definitive”/”Strong”/”Moderate” evidence genes for 3 cardiomyopathies (dilated cardiomyopathy [DCM], hypertrophic cardiomyopathy [HCM], and arrhythmogenic right ventricular cardiomyopathy [ARVC]) and AF. Disease-specific polygenic risk scores (PRSs) for AF, DCM, and HCM were used to stratify study participants into quintiles. The Kaplan-Meier method was used to assess the cumulative incidence from birth to age 75 for AF, DCM, and HCM stratified by carrier status of a PDCv and disease-specific PRS quintile.
Results: Among 346,260 UKB study participants, presence of a PDCv was associated with an increased AF hazard (HR 1.77, 95% CI 1.65 – 1.90; p<0.001), including when restricted to study participants without ventricular cardiomyopathy or heart failure (HR 1.57, 95% CI 1.43 – 1.72, p<0.001). Subdivided by cardiomyopathy gene subtype, carriers of PDCv within DCM (HR: 2.16, 95% CI: 1.98-2.36; p<0.001), ARVC (HR: 1.35, 95% CI: 1.09-1.66; p=0.005) and HCM (HR: 1.31, 95% 1.14 – 1.51; p<0.001) genes all had statistically significant increased hazards of AF. Relative to study participants in the lowest PRSAF quintile without a rare PDCv, study participants in the top PRSAF quintile with a PDCv had a 7.26-fold increased hazard of AF (95% CI 6.29–8.38, p<0.001). The cumulative AF risk for study participants with a rare PDCv and a PRSAF in the top risk quintile was 39.6% relative to 6.7% for study participants without a PDCv and a PRSAF in the lowest risk quintile. The absolute cumulative cardiomyopathy risk among study participants with both a rare PDCv and a disease-specific PRS within the top risk quintile was 5.1% for DCM and 12.3% for HCM.
Conclusions: Putative disease-causing variants within ventricular cardiomyopathy genes are associated with an increased risk of AF in the absence of ventricular cardiomyopathy and clinical heart failure. Despite these genes having been originally identified as culprits for ventricular cardiomyopathy, when integrated with a disease-specific PRS, their impact on the absolute risk for incident AF appears larger relative to that observed for incident DCM and HCM.
  • Da Rocha, Guilherme  ( McMaster University , Hamilton , Ontario , Canada )
  • Belley-cote, Emilie  ( McMaster University , Hamilton , Ontario , Canada )
  • Conen, David  ( McMaster University , Hamilton , Ontario , Canada )
  • Wong, Jorge  ( McMaster University , Hamilton , Ontario , Canada )
  • Mcintyre, William  ( McMaster University , Hamilton , Ontario , Canada )
  • Healey, Jeff  ( McMaster University , Hamilton , Ontario , Canada )
  • Bezzina, Connie  ( University of Amsterdam , Amsterdam , Netherlands )
  • Watkins, Hugh  ( University of Oxford , Oxford , United Kingdom )
  • Ware, James  ( Imperial College London , London , United Kingdom )
  • Tadros, Rafik  ( Montreal Heart Institute , Pierrefonds , Quebec , Canada )
  • Pare, Guillaume  ( McMaster University , Hamilton , Ontario , Canada )
  • Feiner, James  ( McMaster University , Hamilton , Ontario , Canada )
  • Roberts, Jason  ( McMaster University , Hamilton , Ontario , Canada )
  • Lazarte, Julieta  ( McMaster University , Hamilton , Ontario , Canada )
  • Pang, Keona  ( McMaster University , Hamilton , Ontario , Canada )
  • Li, Yanran  ( McMaster University , Hamilton , Ontario , Canada )
  • Le, Ann  ( McMaster University , Hamilton , Ontario , Canada )
  • Man, Alice  ( McMaster University , Hamilton , Ontario , Canada )
  • Pathan, Nazia  ( McMaster University , Hamilton , Ontario , Canada )
  • Whitlock, Richard  ( McMaster University , Hamilton , Ontario , Canada )
  • Author Disclosures:
    Guilherme da Rocha: DO NOT have relevant financial relationships | Emilie Belley-cote: No Answer | David Conen: DO NOT have relevant financial relationships | Jorge Wong: DO NOT have relevant financial relationships | William McIntyre: DO have relevant financial relationships ; Consultant:AtriCure:Active (exists now) ; Speaker:iRhythm:Past (completed) | Jeff Healey: DO have relevant financial relationships ; Research Funding (PI or named investigator):BMS/Pfizer:Past (completed) ; Research Funding (PI or named investigator):Medtronic:Active (exists now) ; Research Funding (PI or named investigator):Boston Scientific:Active (exists now) | Connie Bezzina: No Answer | Hugh Watkins: DO NOT have relevant financial relationships | James Ware: DO have relevant financial relationships ; Research Funding (PI or named investigator):Bristol Myers-Squibb:Active (exists now) ; Ownership Interest:Saturnus Bio:Active (exists now) ; Advisor:Health Lumen; Tenaya Therapeutics; Solid Biosciences; Saturnus Bio:Active (exists now) | Rafik Tadros: DO have relevant financial relationships ; Consultant:Bristol-Myers-Squibb Canada:Active (exists now) ; Research Funding (PI or named investigator):Bristol-Myers-Squibb Canada:Active (exists now) | Guillaume Pare: DO have relevant financial relationships ; Advisor:Amgen:Past (completed) ; Advisor:Sanofi:Past (completed) ; Speaker:HLS Therapeutics:Past (completed) ; Advisor:Bayer:Past (completed) ; Advisor:Novartis:Past (completed) | James Feiner: DO NOT have relevant financial relationships | Jason Roberts: DO NOT have relevant financial relationships | Julieta Lazarte: No Answer | Keona Pang: DO NOT have relevant financial relationships | Yanran Li: No Answer | Ann Le: No Answer | Alice Man: DO NOT have relevant financial relationships | Nazia Pathan: No Answer | Richard Whitlock: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Genomic Insights into Heritable Cardiomyopathies: From Disease Development to Novel Therapies

Monday, 11/10/2025 , 12:15PM - 01:15PM

Moderated Digital Poster Session

More abstracts on this topic:
A Beta Tubulin Mutation Suppresses Arrhythmias and Improves Connexin 43 Localization in Heart of Duchenne Muscular Dystrophy Mice

Zhou Delong, Liu Tong, Yehia Ghassan, Romanienko Peter, Rodney George, Wehrens Xander, Lampe Paul, Gourdie Robert, Xie Lai-hua, Fraidenraich Diego, Nouet Julie, Mesa Elam, Yegneshwaran Vasisht, Geukgeuzian Geovanni, Adibemma Ifeanyichukwu, Nandakumar Swetha, Ramirez Edwin, Li Hong

A Case of Concomitant Wild-Type Transthyretin and Systemic Light Chain Amyloidosis Involving Separate Organs

Chiu Leonard, Afrough Aimaz, Nadeem Urooba, Jebakumar Deborah, Grodin Justin

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available